Home
>
National Drug Code (NDC)
>
Montelukast Sodium
Montelukast Sodium - 0378-6040-93 - (montelukast)
Drug Information of Montelukast Sodium
| Product NDC: | 0378-6040 |
| Proprietary Name: | Montelukast Sodium |
| Non Proprietary Name: | montelukast |
| Active Ingredient(s): | 4 mg/1 & nbsp; montelukast |
| Administration Route(s): | ORAL |
| Dosage Form(s): | GRANULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Montelukast Sodium
| Product NDC: | 0378-6040 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202776 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121219 |
Package Information of Montelukast Sodium
| Package NDC: | 0378-6040-93 |
| Package Description: | 30 GRANULE in 1 CARTON (0378-6040-93) |
NDC Information of Montelukast Sodium
| NDC Code | 0378-6040-93 |
| Proprietary Name | Montelukast Sodium |
| Package Description | 30 GRANULE in 1 CARTON (0378-6040-93) |
| Product NDC | 0378-6040 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | montelukast |
| Dosage Form Name | GRANULE |
| Route Name | ORAL |
| Start Marketing Date | 20121219 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | MONTELUKAST SODIUM |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA] |
